New research is shedding light on why magnesium deficiency may be a silent contributor to insulin resistance. Scientists have discovered that magnesium functions as a critical cofactor in insulin receptor activation, enabling the cellular signaling cascade that allows glucose uptake. When magnesium levels drop, insulin receptor activation plummets by 50%—even when insulin binding and glucose transporters remain normal.
This mechanistic insight explains how metabolic dysfunction can develop despite adequate insulin production. Large population studies corroborate these findings, demonstrating that individuals consuming higher dietary magnesium experience 14-19% reductions in type 2 diabetes risk per 100 mg daily increase. However, approximately half of US adults fail to meet recommended magnesium intake levels (310-420 mg daily), raising public health concerns about widespread deficiency and metabolic risk.
Read the full article on GMJ Newsroom.
Was this article helpful?
